Avantium Technologies BV · Amsterdam The Netherlands
Company Description
View Avantium Technologies BV Locations On A US Map
This link will open in a new window
This link will open in a new window Avantium Technologies aims to advance the drug research process. The company offers research and development services to companies residing in the biotech, pharmaceutical, refining, and specialty chemical markets. Avantium uses its proprietary research platform to solve knotty research problems for more than 70 customers worldwide including AstraZeneca , BP , Pfizer , and Shell . Its areas of specialty include catalysis, molecular modeling, and solid state chemistry. Avantium Technologies, which was formed in 2000, operates two laboratories in the Netherlands. Its investors include Cazenove Group , EDB Investments, and Eastman Chemical . To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Avantium Technologies BV Financials
| Company Type | Private Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $17.0 |
| Employees | 84 |
Avantium Technologies BV Executives
5 executives listed for Avantium Technologies BV's Amsterdam, location.
| Title | Name & Bio | Contact |
| CEO | Tom van Aken | Network |
| VP Operations | Nelleke van der Puil | Network |
| CFO | Frank Roerink | Network |
Competition
Competitive Landscape for Avantium Technologies BV
Demand for biotechnology research in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research. The industry is capital intensive: average annual revenue per worker is more than $350,000. Biotech firms face stiff competition from pharmaceutical and other companies seeking to be first with a new product or discovery. To read the full description, subscribe now.Top Avantium Technologies BV Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!